Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.
about
A functional and regulatory network associated with PIP expression in human breast cancerCirculating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerIdentification of the functional role of peroxiredoxin 6 in the progression of breast cancer.Matrix metalloproteinase-1 promotes muscle cell migration and differentiation.Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis.Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer.Role of Helicobacter pylori on cancer of human adipose-derived mesenchymal stem cells and metastasis of tumor cells-an in vitro study.Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer
P2860
Q21143857-7B53EAE3-9339-470F-A57C-4162A9E112AFQ33514944-7D0277F6-E586-443E-A2D4-329E0C2FB36BQ33768557-90582A4E-F13A-4564-8D60-86AF2CD44559Q33904564-51049C1F-DA31-4199-B217-C5534916E09CQ35586223-E76BB18D-08C8-4A24-A20F-B006CE56C986Q36465265-27AC24EC-BD8E-4989-BF5E-8D81F747631EQ37071885-3F1122F2-6532-4308-BDE3-B4B31E2D5ED2Q37351433-2A207FBE-E9BF-479D-BD2A-D9BBE74148DEQ37366248-0BE7134F-7B4B-4909-8A48-EA6CDA4C21E7Q37386814-096FFD69-E2B7-48B5-96E4-4AC9075FC21BQ38366856-ABD3837B-6617-45FC-97D7-B1FF1B5FC95DQ38955493-68E2DE81-8DF9-40C5-B800-CC058CD13F12Q39689348-C42926D0-3657-4B77-A7EE-45BC8949609FQ57116710-F9ECA965-6954-4D3A-91D1-7C54DD031B32
P2860
Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@en
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@nl
type
label
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@en
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@nl
prefLabel
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@en
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@nl
P2093
P2860
P1476
Expression of MT-1 MMP, MMP2, ...... uctal carcinoma of the breast.
@en
P2093
Byeong Woo Park
Chan-il Park
Hee Jung Kim
Woo Hee Jung
P2860
P304
P356
10.3349/YMJ.2006.47.3.333
P577
2006-06-01T00:00:00Z